Boston Scientific Corp (BSX)
$44.67+1.06%
Spriggl Score: Strong— sign in to explore; full breakdown with Premium
Last 30 trading days
Spriggl AI Verdict
“Leading cardiac device maker with strong long-run growth; 2026 slowdown and heavy acquisition debt are near-term concerns.”
Sign up free to read the full investment thesis, bull case, bear case and what to watch.
About Boston Scientific Corp
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. The company operates in two segments, MedSurg and Cardiovascular. It offers devices to diagnose and treat a range of gastrointestinal…
- Sector:
- Healthcare
- Industry:
- Medical Devices
- Market Cap:
- $67.3B
Recent dividends
No recent dividends recorded.
Get the full Spriggl analysis — free
A free Spriggl account gets you the screener, a watchlist, AI verdicts and a free full report every day — across Boston Scientific Corp and 1,500+ UK and US stocks. The full score breakdown and AI analysis come with Premium.
Start free